Gene changes in nasal cells of RLS patients on long-term dopamine agonist
Part of Brain & nervous system, Mental health clinical trials.
This study looks at changes in a gene (DRD2) in nasal cells of people with Restless Legs Syndrome who are taking a dopamine agonist medication for a long time. It aims to understand how this gene might be involved in RLS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Restless Legs Syndrome (RLS).
- You are currently taking a dopamine agonist medication for your RLS.
- You are not using any medications or substances that could affect the cells collected from your nose with a swab.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that sends mild electrical signals to the spinal cord to see if it can reduce severe restless legs syndrome symptoms when standard medicines haven't helped enough.
This study tests whether a spinal cord stimulator can help people with restless leg syndrome (RLS). It compares people with RLS to healthy volunteers to see if the device reduces symptoms.
This study tests whether a spinal cord stimulator (a device that sends mild electrical pulses to the spinal cord) can help reduce severe restless legs syndrome (RLS) symptoms that have not improved with medication. If you have severe RLS, this could be a new way to find relief.
This trial tests a new drug (a calcium channel modulator) to see how well it works and how safe it is for people with moderate to severe restless legs syndrome (RLS). It may offer a new treatment option for those with typical or variant RLS.
This study tests a device that delivers nerve stimulation to help with restless legs syndrome (RLS). It aims to see if using the device for a longer period each night can reduce RLS symptoms and improve sleep.
This trial studies how a single session of exercise changes blood markers in people with restless legs syndrome (RLS) who are not currently being treated. If you have moderate to severe RLS and are not regularly active, this study may help us understand how exercise affects your condition.
Hear when a new Restless Leg Syndrome (RLS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.